Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial.
Gardener SL, Fuller SJ, Naismith SL, Baker L, Kivipelto M, Villemagne VL, Grieve SM, Yates P, Rainey-Smith SR, Chen J, Thompson B, Armstrong NJ, Fernando MG, Blagojevic Castro C, Meghwar S, Raman R, Gleason A, Ireland C, Clarnette R, Anstey KJ, Taddei K, Garg M, Sohrabi HR, Martins RN. Gardener SL, et al. Among authors: villemagne vl. Alzheimers Dement (N Y). 2024 Apr 9;10(2):e12466. doi: 10.1002/trc2.12466. eCollection 2024 Apr-Jun. Alzheimers Dement (N Y). 2024. PMID: 38596483 Free PMC article.
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D; AIBL Research Group. Ellis KA, et al. Int Psychogeriatr. 2009 Aug;21(4):672-87. doi: 10.1017/S1041610209009405. Epub 2009 May 27. Int Psychogeriatr. 2009. PMID: 19470201
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.
Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Research Group. Chételat G, et al. Among authors: villemagne vl. Ann Neurol. 2010 Mar;67(3):317-24. doi: 10.1002/ana.21955. Ann Neurol. 2010. PMID: 20373343
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.
Lui JK, Laws SM, Li QX, Villemagne VL, Ames D, Brown B, Bush AI, De Ruyck K, Dromey J, Ellis KA, Faux NG, Foster J, Fowler C, Gupta V, Hudson P, Laughton K, Masters CL, Pertile K, Rembach A, Rimajova M, Rodrigues M, Rowe CC, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ward V, Martins RN, AIBL Research Group. Lui JK, et al. Among authors: villemagne vl. J Alzheimers Dis. 2010;20(4):1233-42. doi: 10.3233/JAD-2010-090249. J Alzheimers Dis. 2010. PMID: 20413897
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.
Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL. Rowe CC, et al. Among authors: villemagne vl. Neurobiol Aging. 2010 Aug;31(8):1275-83. doi: 10.1016/j.neurobiolaging.2010.04.007. Epub 2010 May 15. Neurobiol Aging. 2010. PMID: 20472326
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group. Chételat G, et al. Among authors: villemagne vl. Brain. 2011 Mar;134(Pt 3):798-807. doi: 10.1093/brain/awq383. Epub 2011 Feb 9. Brain. 2011. PMID: 21310725
Advances in structural and molecular neuroimaging in Alzheimer's disease.
Ellis KA, Rowe CC, Szoeke CE, Villemagne VL, Ames D, Chételat G, Martins RN, Masters CL, Fripp J, Acosta O, Raniga P, Bourgeat PT, Salvado O. Ellis KA, et al. Among authors: villemagne vl. Med J Aust. 2011 Feb 21;194(4):S20-3. doi: 10.5694/j.1326-5377.2011.tb02938.x. Med J Aust. 2011. PMID: 21401483
Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.
Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, Lui JK, Masters C, Rowe CC, Szoeke C, Taddei K, Martins RN; AIBL Research Group. Gupta VB, et al. Among authors: villemagne vl. Neurology. 2011 Mar 22;76(12):1091-8. doi: 10.1212/WNL.0b013e318211c352. Neurology. 2011. PMID: 21422459
415 results